Ledger.
Investor · St. Louis, MO

Michael B. Wainscott

Open Michael in the network graph →
Filings
10
SEC Form D
Connections
82
co-filers
Capital
$309.1M
across filings
Active
Dec 2019
to Jul 2023

Most-connected co-filers (82)

Chris C. Wilkins · St. Louis, MO8 sharedNatalie B. Dinicola · St. Louis, MO8 sharedMatthew B. Crisp · Durham, NC6 sharedAndy M. Wheeler · St. Louis, MO6 sharedDan B. Jacobi · Durham, NC4 sharedNilesh C. Kumar · Watertown, MA3 sharedL. A. Hodges · Fort Worth, TX3 sharedRichard J. O'Toole · New York, NY3 sharedSharon Love · NEW YORK, NY3 sharedAymeric S. Sallin · Watertown, MA3 sharedJustin G. Lioi · New York, NY3 sharedPeter E. Wirth · Cambridge, MA3 sharedAndrew Newcomb · Philadelphia, PA3 sharedDan N. Watkins · Durham, NC3 sharedKenneth Wong · New York, NY3 sharedSanjeev Krishnan · St. Louis, MO3 sharedRonald J. Seubert · Seattle, WA3 sharedAndrew J. Schwab · Seattle, WA3 sharedJoseph J. Victor Jr · Seattle, WA3 sharedMichael J. Metzger · Watertown, MA3 sharedGuido J. Magni · Watertown, MA3 sharedDennis J. Ausiello · Watertown, MA3 sharedPeter Feret · NEW YORK, NY3 sharedAdrienne D. Elsner · St. Louis, MO3 shared

Recent filings (10)

RareCyte, Inc.Jul 2023 · 22 co-filers$35.7MTarveda Therapeutics, Inc.Sep 2021 · 17 co-filers$6.0MRareCyte, Inc.Sep 2021 · 20 co-filers$24.0MTarveda Therapeutics, Inc.Dec 2020 · 17 co-filers$15.4MBenson Hill, Inc.Dec 2020 · 37 co-filers$159.1MBenson Hill, Inc.Nov 2020 · 37 co-filers$150.0MTarveda Therapeutics, Inc.Dec 2019 · 20 co-filers$13.6MRareCyte, Inc.Dec 2019 · 16 co-filers$22.2MBenson Hill Biosystems, Inc.Aug 2019 · 12 co-filers$32.6MBenson Hill Biosystems, Inc.Nov 2018 · 16 co-filers$65.0MBenson Hill Biosystems, Inc.Nov 2018 · 16 co-filers$65.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Michael in the interactive graph →